Medicare Enrolled

Dr. Samuel Geurkink, DO

Hematology & Oncology · Ft Worth, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
9750 HILLWOOD PKWY, Ft Worth, TX 76177
8176975620
In practice since 2017 (8 years)
NPI: 1932638467 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Geurkink from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geurkink? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Geurkink

Dr. Samuel Geurkink is a hematology & oncology specialist in Ft Worth, TX, with 8 years of NPI registration. Based on federal Medicare data, Dr. Geurkink performed 409 Medicare services across 249 unique beneficiaries.

Between the years covered by Open Payments, Dr. Geurkink received a total of $2,462 from 44 pharmaceutical and/or device companies across 114 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Geurkink is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ 409 Medicare services $2,462 industry payments

Medicare Practice Summary

Medicare Utilization ↗
409
Medicare services
Bottom 26% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
249
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
96 $8 $20
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
89 $8 $36
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
71 $10 $64
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
43 $100 $368
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
30 $6 $31
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
22 $13 $60
Iron level test 22 $6 $27
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
22 $9 $35
New patient office visit, complex (60-74 min) 14 $159 $709
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,462
Total received (2018-2024)
Avg $492/year across 5 years
Bottom 45% in TX for hematology & oncology
44
Companies
114
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,297 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$165 (6.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,726
2023
$313
2020
$30
2019
$230
2018
$162

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$249
Celgene Corporation
$193
PFIZER INC.
$186
Lilly USA, LLC
$165
Merck Sharp & Dohme LLC
$119
Novartis Pharmaceuticals Corporation
$112
Takeda Pharmaceuticals U.S.A., Inc.
$105
E.R. Squibb & Sons, L.L.C.
$100
GlaxoSmithKline, LLC.
$84
ABBVIE INC.
$76
GENZYME CORPORATION
$64
PORTOLA PHARMACEUTICALS, INC.
$63
ARRAY BIOPHARMA INC
$61
Alexion Pharmaceuticals, Inc.
$56
Incyte Corporation
$50
Eisai Inc.
$48
Pharmacosmos Therapeutics Inc.
$45
Daiichi Sankyo Inc.
$42
Regeneron Healthcare Solutions, Inc.
$39
Gilead Sciences, Inc.
$38
Bayer Healthcare Pharmaceuticals Inc.
$36
INTUITIVE SURGICAL, INC.
$34
EMD Serono, Inc.
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Kite Pharma, Inc.
$32
Janssen Pharmaceuticals, Inc
$31
TETRAPHASE PHARMACEUTICALS, INC.
$31
Mirati Therapeutics, Inc.
$29
Tempus AI, Inc
$28
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$25
Stemline Therapeutics Inc.
$24
MorphoSys, US Inc.
$23
Agios Pharmaceuticals, Inc.
$21
Jazz Pharmaceuticals Inc.
$20
Secura Bio, Inc.
$20
Adaptive Biotechnologies Corporation
$19
TerSera Therapeutics LLC
$17
Immunocore Limited
$17
Puma Biotechnology, Inc.
$16
Shire North American Group Inc
$13
Aveo Pharmaceuticals, Inc.
$13
Janssen Biotech, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 25.5% of total payments
Associated products mentioned in payments ›
BEVYXXA · BRILINTA · CABLIVI · CALQUENCE · CHANTIX · COPIKTRA · DIFICID · Da Vinci Surgical System · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · ENTRESTO · EPKINLY · ERLEADA · Enhertu · FOTIVDA · FRUZAQLA · GATTEX · GILOTRIF · IBRANCE · ICLUSIG · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · LIBTAYO · LOKELMA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · OJJAARA · OPDIVO · Orserdu · PADCEV · PYRUKYND · Pomalyst · REBLOZYL · SARCLISA · Stivarga · ULTOMIRIS · VENCLEXTA · VERZENIO · Vanflyta · XALKORI · XARELTO · XIFAXAN · Xerava · Xermelo · Yescarta · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $602 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Ft Worth?
Compare hematology & oncology specialists in the Ft Worth area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
55
Per 100K population
2.6
County median income
$81,905
Nearest hospital
MEDICAL CITY MENTAL HEALTH AND WELLNESS CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Geurkink is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Geurkink experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Geurkink performed 96 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Geurkink receive payments from pharmaceutical companies?
Yes. Dr. Geurkink received a total of $2,462 from 44 companies across 114 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Geurkink's costs compare to other hematology & oncology specialists in Ft Worth?
Dr. Geurkink's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Geurkink) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →